Category: Women’s Health · Menopause · Female Pattern Hair Loss
Crown Thinning, Chin Hair, and Oily Skin at Menopause: Do Androgens Really Take Over, Which Hair Treatments Have Evidence, and Which Symptoms Need Testing
AI Overview / Quick Answer (BLUF)
Across menopause, estrogen falls and the binding protein SHBG drops about 43% while testosterone holds steady, so free androgens rise relative to estrogen. Topical minoxidil has strong evidence for female pattern hair loss, biotin helps only when deficient, and fast hair growth with a deepening voice needs a tumor workup.
From our reader group: thinner on top, but new hair on the chin
Several members of a menopause discussion group described the same pattern as their periods stopped: the crown thinned until the scalp showed and the part widened,
while coarse hairs appeared on the chin and upper lip, the face became oilier, and the belly grew despite eating the same. They asked whether male hormones were to blame.
Short answer: this cluster fits a shift in hormone balance, not a rise in male hormone production, and this kind of thinning does not scar the follicle, so it remains treatable.
What needs separating out is symptoms that progress unusually fast, which can come from a hormone-producing tumor. If graying is also on your mind, see
Gray Hair in Your Mid-40s with Hot Flashes: Causes, PPD Hair Dye, and Silver Hair Care
Warning signs — symptoms that should not wait
Direct answer: gradual thinning and a few chin hairs can wait for a routine appointment, but the symptoms below need prompt medical review.
An endocrine review states that serum testosterone above 5 nmol/L with masculinizing signs calls for prompt investigation to rule out an androgen-producing tumor first
(Hirschberg 2023).
See a gynecologist or endocrinologist within a few weeks
- Body or facial hair increasing quickly over a few months, with a deepening voice, an enlarging clitoris, or a male-type receding hairline can come from an ovarian or adrenal tumor that makes hormones
- Any vaginal bleeding after periods have stopped always needs the uterine lining checked
- Unintended weight loss, a quickly enlarging abdomen, or a lump you can feel in the belly
See a dermatologist soon, because some types do not regrow
- A band-like recession of the front and temple hairline with smooth, shiny skin and thinning eyebrows may be a scarring alopecia that is common after menopause
- A red, burning, painful scalp with pustules or thick crusts
- Round, sharply outlined bald patches
- Handfuls of hair shedding all over the scalp within a few weeks, especially after high fever, surgery, a new medicine, or rapid weight loss
- Hair loss with fatigue, pallor, palpitations, feeling cold, or unusually dry skin warrants thyroid and iron testing
1. Do androgens really “take over” at menopause?
Direct answer: yes in proportion, not in amount. A study that followed 172 women through menopause found total testosterone did not change with the final period, but SHBG fell 43% and the free androgen index rose 80%
(Burger 2000).
SHBG is the blood protein that binds sex hormones. When it falls, the free, active share of androgens rises, while the estrogen that used to balance it declines.
Testosterone declines with age, not suddenly at menopause
A study of 1,423 women aged 18–75 found androgens fall steeply in the early reproductive years and natural menopause adds no extra drop,
because the postmenopausal ovary keeps producing testosterone. Women who had both ovaries removed had lower levels
(Davison 2005).
Data from 172 Australian women followed through menopause (Burger 2000). Group averages; individuals vary.
Why the belly grows at the same time
The SWAN study measured body composition by DXA every year and found that when the menopause transition began, the rate of fat gain doubled and lean mass declined, continuing until 2 years after the final period,
even though total weight did not rise faster
(Greendale 2019).
Postmenopausal androgen excess is also linked with abdominal fat and insulin resistance
(Hirschberg 2023).
For exercise guidance on belly fat, see
Over 50 and Past Menopause: Why Some Women Stay Fit
Total testosterone does not rise. What changes is lower SHBG and lower estrogen, while DHEA declines with age rather than with the date of menopause.
Most women with this type of thinning have normal blood androgen levels.
2. Menopausal thinning comes in several types — identify the type before treating
Direct answer: thinning over the crown with a widening part but a preserved front hairline fits female pattern hair loss, which is a common cause of hair loss in women.
With each hair cycle the growth phase shortens, follicles shrink, and thick hairs turn into fine, short vellus hairs
(van Zuuren 2016).
What DHT does to the follicle
Inside the follicle, the enzyme 5-alpha reductase converts testosterone into DHT, which binds the androgen receptor more strongly and signals the growth phase to shorten.
Most women with this pattern have normal blood androgens. One study proposed that a lower estradiol-to-free-testosterone ratio may be the trigger in genetically susceptible women
(Riedel-Baima 2008),
but research has not established that female pattern hair loss is entirely androgen-driven
(Sinclair 2005).
Why the scalp thins while the chin grows hair
DHT acts in opposite directions depending on location. On the scalp it shrinks follicles, but on the chin, upper lip, and chest it turns fine vellus hair into coarse dark hair
and stimulates oil glands, causing oily skin and acne. That is why all three can appear together
(Hirschberg 2023).
How many times more strongly DHT binds the receptor than testosterone varies with the measurement method; the usable conclusion is simply that DHT is more potent.
The type that truly destroys follicles is scarring alopecia, which needs a dermatologist early.
Table: types of hair thinning seen around menopause
For orientation only. Several types can coexist, and diagnosis requires a dermatologist to examine the scalp.
| Type | Pattern | Clues | What to do |
|---|---|---|---|
| Female pattern hair loss | Crown thinning, part widening in a Christmas-tree shape, gradual over years | Front hairline preserved; hairs of mixed thickness | See a dermatologist; start minoxidil as advised |
| Excess shedding (telogen effluvium) | Diffuse shedding; hairs fall with a white bulb | Starts 2–3 months after fever, surgery, stress, a new drug, or rapid weight loss | Find the trigger; check thyroid and iron; usually settles once the cause is fixed |
| Patchy hair loss (alopecia areata) | Smooth round patches with sharp edges, rapid onset | Skin smooth without scarring; may affect eyebrows or other body hair | See a dermatologist for immune-directed treatment |
| Scarring loss at the front hairline | Band-like recession at forehead and temples; thinning eyebrows | Smooth shiny skin without follicle openings; common after menopause | See a dermatologist early, because lost follicles do not return |
| Thinning from androgen excess | Thinning with fast-growing body hair and a deepening voice | Progresses over months, not years | Testosterone test, ovarian ultrasound, and adrenal imaging |
Scarring alopecia of the front hairline is common in postmenopausal women. It appears as a smooth band of recession at the forehead and temples, often with eyebrow loss,
and is being diagnosed more widely
(Alenezi 2026).
Where does your hair thinning or shedding sit right now?
Analyze your severity level and receive personalized guidance from our Advisory team. This assessment helps you see which pattern your hair loss fits, how severe it is, and when to see a dermatologist.
It is not a diagnosis. If you have any warning sign listed above, book a medical visit without waiting for a score.
3. Evidence-based treatment: minoxidil, antiandrogens, and hormone therapy
Direct answer: topical minoxidil has better evidence for female pattern hair loss than any other option. A Cochrane review of 47 trials with 5,290 women found visible regrowth was 1.93 times more likely with minoxidil than placebo,
with an average gain of 13.18 hairs per square centimeter, while finasteride 1 mg was no better than placebo
(van Zuuren 2016).
Topical minoxidil
In the Cochrane review, 2% and 5% strengths worked about the same. Once-daily 5% foam was non-inferior to twice-daily 2% solution and caused less itching and flaking
(Blume-Peytavi 2011).
In the first 2–8 weeks shedding may increase temporarily, a sign that follicles are entering a new cycle. Judge the result at about 6 months, and keep using it, because hair thins again over several months after stopping.
Low-dose oral minoxidil
A review of 17 studies with 634 patients found low-dose oral minoxidil to be an effective, well-tolerated option for healthy people who cannot use the topical form.
Side effects to watch are facial and body hair growth, ankle swelling, palpitations, and low blood pressure
(Randolph 2021).
Anyone who already has chin hair should discuss this before starting, and people with heart disease need a medical assessment first.
Spironolactone
A diuretic with antiandrogen activity, used off-label for hair thinning in women. In a study of 80 women on oral antiandrogens for 12 months, 44% had regrowth, 44% were stable, and 12% kept losing hair
(Sinclair 2005).
A meta-analysis found an overall improvement rate of 56.6%, higher when combined with minoxidil, but the studies varied widely
(Aleissa 2023).
Potassium and kidney function need checking before and during use, especially for anyone taking ACE inhibitor or ARB blood-pressure medicines.
Cyproterone acetate
A randomized trial of 66 women found minoxidil worked better when no other androgen-excess signs were present, while cyproterone acetate worked better when oily skin, acne, and hirsutism were present
(Vexiau 2002).
However, a French study of 253,777 women found high-dose use was linked with a 6.6-fold higher risk of meningioma, rising to 21.7-fold above a cumulative 60 g, with risk falling after stopping
(Weill 2021).
It is therefore not a first choice for hair thinning and should be used only under medical supervision.
Menopausal hormone therapy with an antiandrogenic progestin
Estradiol combined with drospirenone is a hormone therapy whose progestin has mild antiandrogen activity, and it has been studied for long-term safety in a randomized trial after menopause
(Archer 2005).
No trial has yet used hair density as a primary outcome, so the decision to use hormone therapy rests on hot flashes, sleep, and the risks of breast cancer, blood clots, and heart disease, not on hair alone.
Hormone therapy reduced abdominal fat by about 6.8% in a meta-analysis of 107 trials
(Salpeter 2006),
a small effect that is not a main reason to start it.
Managing chin hair and oily skin
The Endocrine Society guideline recommends testing testosterone in women with hirsutism and combining direct hair removal with medication according to severity.
It was written for premenopausal women, so the principles apply, but after menopause a tumor must always be excluded first
(Martin 2018).
A few chin hairs can be tweezed or removed directly. Laser works on dark hair but much less on white or gray hair. Eflornithine cream slows facial hair regrowth while it is used.
The option with better evidence is minoxidil, which the shared post never mentioned, and cyproterone acetate carries a meningioma risk that grows with cumulative dose.
Choosing a medicine should go through a dermatologist or gynecologist.
Comparison table: treatment options for menopausal hair thinning and hirsutism
Generic and class names for education only. Starting, adjusting, or stopping any medicine requires a clinician’s assessment.
| Option | Best fit | Evidence | Time to effect | Cautions |
|---|---|---|---|---|
| Topical minoxidil 2% or 5% | Female pattern hair loss at any stage | 1.93 times placebo, moderate-quality evidence (van Zuuren 2016) | Assess at about 6 months | Itch, flaking, early shedding; thinning returns after stopping |
| Low-dose oral minoxidil | People who cannot tolerate the topical form | 17 studies, 634 patients; larger trials needed (Randolph 2021) | Several months | Facial hair, ankle swelling, palpitations, low blood pressure |
| Spironolactone | Thinning with oily skin, acne, or hirsutism | About 56.6% improved in a meta-analysis; studies varied widely (Aleissa 2023) | 6–12 months | Check potassium and kidneys; dizziness; off-label use |
| Cyproterone acetate | Clear androgen-excess signs, at a clinician’s discretion | Works better when androgen-excess signs coexist (Vexiau 2002) | 6–12 months | Meningioma risk rises with cumulative dose (Weill 2021) |
| Hormone therapy: estradiol with drospirenone | Menopausal symptoms that already need treatment | Safety data available; no hair-outcome trial (Archer 2005) | Hot flashes improve within weeks | Assess breast, clot, heart, and potassium risks |
| Finasteride | Not a first choice in women | 1 mg no better than placebo (van Zuuren 2016) | Unclear | Contraindicated if pregnancy is possible |
| Correcting iron, zinc, or protein deficiency | People with a confirmed deficiency | Helps when deficient; no evidence without deficiency (Almohanna 2019) | 2–3 months after correction | Excess zinc causes copper deficiency; excess iron accumulates |
| Biotin supplements | Only true biotin deficiency, which is uncommon | No evidence in healthy people (Patel 2017) | No data in people who are not deficient | Interferes with blood tests such as thyroid and troponin |
| Direct hair removal (tweezing, laser, eflornithine cream) | Bothersome chin or upper-lip hair | Part of hirsutism guideline care (Martin 2018) | Immediate to several weeks | Laser works poorly on white hair; exclude a tumor first if growth is fast |
4. Protein, iron, zinc, and biotin: when do they help?
Direct answer: nutrients help hair when the body is actually deficient. A review of vitamins and minerals concluded that large trials in people with both deficiency and hair loss are still needed before supplements can be recommended generally
(Almohanna 2019).
Iron and ferritin
Serum ferritin confirms iron deficiency. After menopause there is no menstrual blood loss, so if iron deficiency is found, the source of blood loss must be sought,
especially from the digestive tract, such as colon cancer, before assuming it is only a hair issue
(Trost 2006).
Zinc
Zinc is needed for cell division in the follicle, but long-term excess supplementation causes copper deficiency, leading to anemia and low white cell counts
(Fosmire 1990).
Zinc’s ability to inhibit 5-alpha reductase comes from laboratory experiments; no human trial has shown it improves female pattern hair loss.
Biotin
A review found 18 reported cases of hair or nail improvement after biotin, and every one had an underlying disease or biotin deficiency. Evidence is insufficient for healthy people
(Patel 2017).
High-dose biotin also distorts some blood tests, such as thyroid-stimulating hormone and troponin, which is used to diagnose heart attacks
(Mzougui 2020).
Anyone taking it should tell their clinician and the laboratory before every blood draw.
Protein
Hair keratin is rich in the amino acid cysteine, which forms the disulfide bonds that give hair strength. Eating enough protein from fish, eggs, legumes, and dairy corrects a shortfall,
but protein beyond your needs does not thicken follicles that have shrunk under hormonal influence.
The claim that zinc naturally blocks 5-alpha reductase comes from laboratory data, not human results.
Nutrients correct deficiencies; they are not the main treatment for female pattern hair loss.
Table: what to test for hair thinning around menopause
Clinicians choose tests by symptoms and history; not everyone needs every test.
| Test | What it shows | Check when |
|---|---|---|
| Complete blood count and ferritin | Iron deficiency and anemia | Diffuse shedding, fatigue, pallor |
| Thyroid-stimulating hormone | Under- or overactive thyroid | Hair loss with feeling cold, dry skin, or palpitations |
| Total testosterone and SHBG | Androgen level | Hirsutism, acne, or fast-progressing symptoms |
| DHEA-S | Adrenal androgen | Suspected adrenal source |
| Transvaginal ultrasound or CT/MRI | Ovarian or adrenal mass | Very high testosterone or masculinizing signs |
5. Scalp care and tracking your own progress
Direct answer: scalp care reduces irritation and breakage but does not treat shrunken follicles. Photos every 3 months show whether treatment is working.
- Wash with a gentle shampoo suited to your scalp’s oiliness. If you have greasy flakes or itching, have a clinician check for seborrheic dermatitis.
- Photograph the crown and part from the same angle and lighting every 3 months.
- Skip tight ponytails, very hot blow-drying, and frequent straightening or perming, which cause breakage and traction hair loss.
- If you dye your hair, patch-test on the forearm every time and pause dyeing while the scalp is irritated by a topical treatment.
- Sleep enough and manage stress, because severe stress can trigger shedding on top of female pattern hair loss.
Suggested order of care
Myths worth correcting
After menopause the body makes more male hormone
Total testosterone does not rise. What changes is lower estrogen and lower SHBG, so free androgens become relatively dominant.
Biotin will thicken your hair
Biotin helps only people who are deficient, which is uncommon, and high doses can distort thyroid and heart blood tests.
Hormone therapy treats hair thinning
No trial has used hair as a primary outcome. Hormone therapy is used for menopausal symptoms after a risk assessment. The medicine with evidence for hair is minoxidil.
A thin crown means the roots are dead
Female pattern hair loss does not scar follicles. They shrink but remain, so they respond to treatment, and the earlier you start, the more density you keep.
Chin hair is always just a normal part of menopause
A few slowly growing hairs are common, but hair that grows quickly over a few months with a deepening voice needs testing for a hormone-producing tumor.
Frequently Asked Questions (FAQ)
Why does menopause thin the crown, grow chin hair, and make the face oily?
Around menopause, estrogen and the binding protein SHBG both fall, so free androgens become relatively dominant. In scalp follicles DHT shortens the growth phase, but on the chin it turns fine hair into coarse hair and stimulates oil glands, so all three symptoms can appear together.
Does testosterone go up after menopause?
No. A study following women through menopause found total testosterone did not change, while SHBG fell about 43% and the free androgen index rose about 80%. Testosterone declines slowly with age, and the postmenopausal ovary keeps producing it.
How does DHT damage hair follicles, and are they permanently dead?
DHT binds androgen receptors in the follicle and shortens the growth phase with each cycle, so hairs become finer and shorter. Female pattern hair loss does not scar, so follicles remain and respond to medicine. Scarring alopecia, which destroys follicles permanently, needs a dermatologist early.
Which medicines have evidence for female pattern hair loss?
Topical minoxidil has better evidence than other options. A Cochrane review found visible regrowth 1.93 times more often than with placebo, and 2% and 5% work about the same. People who cannot use the topical form may use low-dose oral minoxidil, and those with androgen-excess signs may add spironolactone if a clinician advises it.
Can antiandrogenic menopausal hormone therapy help my hair?
Estradiol with drospirenone contains a progestin with mild antiandrogen activity, but no trial has measured its effect on hair directly. Hormone therapy is decided by menopausal symptoms and the risks of breast cancer, blood clots, and heart disease. High-dose cyproterone acetate is linked with meningioma.
Do biotin, zinc, and protein make hair grow?
They help when the body is deficient. Biotin has no evidence in healthy people and high doses distort blood tests, and excess zinc causes copper deficiency. Eat enough protein, and ask a clinician to check ferritin if shedding is diffuse or you feel fatigued.
What kind of chin hair growth needs a tumor workup?
Hair that grows quickly over a few months, together with a deepening voice, an enlarging clitoris, or a male-type receding hairline, needs a testosterone test. If it is above 5 nmol/L, clinicians image the ovaries and adrenal glands to look for a hormone-producing tumor. A few slowly growing hairs are common at this age.
How long before hair treatment works, and can I stop it?
Minoxidil needs about 6 months before results can be judged, and shedding may rise briefly at first. After stopping, new hair gradually thins again over several months, so use it continuously and talk to your clinician before stopping or switching.
Scientific Mechanism
SHBG and free hormones: the liver makes more SHBG when estrogen is present and less as weight and insulin resistance rise.
Across menopause SHBG therefore falls with estradiol and body mass index, and the unbound share of androgens increases even though the total stays the same
(Burger 2000).
The hair cycle: in androgen-sensitive follicles, DHT binds receptors in the dermal papilla, shortening the growth phase and shrinking the follicle with each cycle.
Minoxidil opens potassium channels and increases blood flow, lengthening the growth phase without acting on hormones, which is why it works even when blood hormone levels are normal
(van Zuuren 2016).
Opposite effects by site: follicles on the chin and upper lip respond to androgens by enlarging, while scalp follicles respond by shrinking.
Oil glands are also androgen-sensitive, so oily skin, acne, hirsutism, and thinning are signs of the same hormonal axis
(Hirschberg 2023).
Body composition: during the menopause transition, fat accumulates faster and lean mass declines. Rising abdominal fat is linked with insulin resistance, which suppresses SHBG further,
creating a loop that makes free androgens more dominant. Resistance exercise and weight management therefore help both metabolism and hormone balance
(Greendale 2019).
Compiled and reviewed by Asst. Prof. Dr. Norawit Raatpiboon
Academic References (E-E-A-T)
- Burger HG et al. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab 2000 (PMID 10946891)
- Davison SL et al. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 2005 (PMID 15827095)
- Riedel-Baima B, Riedel A. Female pattern hair loss may be triggered by low oestrogen to androgen ratio. Endocr Regul 2008 (PMID 18333699)
- Greendale GA et al. Changes in body composition and weight during the menopause transition. JCI Insight 2019 (PMID 30843880)
- Salpeter SR et al. Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes Metab 2006 (PMID 16918589)
- Hirschberg AL. Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman. J Clin Endocrinol Metab 2023 (PMID 36409990)
- van Zuuren EJ, Fedorowicz Z, Schoones J. Interventions for female pattern hair loss. Cochrane Database Syst Rev 2016 (PMID 27225981)
- Blume-Peytavi U et al. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women. J Am Acad Dermatol 2011 (PMID 21700360)
- Randolph M, Tosti A. Oral minoxidil treatment for hair loss: A review of efficacy and safety. J Am Acad Dermatol 2021 (PMID 32622136)
- Sinclair R, Wewerinke M, Jolley D. Treatment of female pattern hair loss with oral antiandrogens. Br J Dermatol 2005 (PMID 15787815)
- Aleissa M. The Efficacy and Safety of Oral Spironolactone in the Treatment of Female Pattern Hair Loss: A Systematic Review and Meta-Analysis. Cureus 2023 (PMID 37719557)
- Vexiau P et al. Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial. Br J Dermatol 2002 (PMID 12072067)
- Weill A et al. Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study. BMJ 2021 (PMID 33536184)
- Archer DF et al. Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial. Menopause 2005 (PMID 16278615)
- Martin KA et al. Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2018 (PMID 29522147)
- Patel DP, Swink SM, Castelo-Soccio L. A Review of the Use of Biotin for Hair Loss. Skin Appendage Disord 2017 (PMID 28879195)
- Mzougui S et al. Biotin interference: evaluation of a new generation of electrochemiluminescent immunoassays for high-sensitive troponin T and thyroid-stimulating hormone testing. Clin Chem Lab Med 2020 (PMID 32324155)
- Almohanna HM et al. The Role of Vitamins and Minerals in Hair Loss: A Review. Dermatol Ther (Heidelb) 2019 (PMID 30547302)
- Trost LB, Bergfeld WF, Calogeras E. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol 2006 (PMID 16635664)
- Fosmire GJ. Zinc toxicity. Am J Clin Nutr 1990 (PMID 2407097)
- Alenezi S, Ezzat RZ, Miteva M. Frontal fibrosing alopecia part I – Diagnosis and clinical presentation. J Am Acad Dermatol 2026 (PMID 39824360)
Medical Disclaimer
This article provides general educational information about hair thinning and hirsutism around menopause. It is not a diagnosis, prescription, or personal treatment plan.
Drug names are generic names for education only. Starting, adjusting, or stopping any medicine or hormone requires a discussion with your treating clinician.
If you have any of the warning signs above, seek medical care promptly.